Sfoglia per AUTORE
TAJANA M
Collezione AO Cuneo

  

Items : 4

Clinical significance of chromatin-spliceosome acute myeloid leukemia: a report from the Northern Italy Leukemia Group (NILG) randomized trial 02/06. in Haematologica / Haematologica. 2021 Oct 1;106(10):2578-2587. doi: 10.3324/haematol.2020.252825.

2021
AOU Alessandria
AO Cuneo
AOU Città della Salute di Torino

Rambaldi A; Spinelli O; Pavoni C; Bassan R; Cortelezzi A; Falini B; Todisco E; Bernardi M; Campiotti L; Ciceri F; Mattei D; Corradini P; Scattolin AM; Cavattoni I; Tajana M; Ferrero D; Audisio E; Terruzzi E; De Paoli L; Cattaneo C; Borlenghi E; Mannelli F; Gianfaldoni G; Grassi A; Delaini F; Oldani E; Intermesoli T; Michelato A; Elidi L; et alii...

High Throughput Molecular Characterization of Normal Karyotype Acute Myeloid Leukemia in the Context of the Prospective Trial 02/06 of the Northern Italy Leukemia Group (NILG). in Cancers / Cancers (Basel). 2020 Aug 11;12(8):2242. doi: 10.3390/cancers12082242.

2020
AO Cuneo
AOU Città della Salute di Torino
AOU Alessandria

Spinelli O; Rambaldi A; Bassan R; Fracchiolla N; Corradini P; Campiotti L; Todisco E; Scattolin A; Ciceri F; Tajana M; Mattei D; Cavattoni I; Borlenghi E; De Paoli L; Audisio E; Terruzzi E; Gianfaldoni G; Oldani E; Lussana F; Intermesoli T; Caprioli C; Stefanoni P; Buklijas K; Elidi L; Michelato A; Salmoiraghi S; Pavoni C; Zanghì P; Cavagna R; et alii...

Molecular prolife by next generation sequencing of acute myeloid leukemia with normal karyotype: Clinical results from the prospective trial 02/06 of the Northern Italy leukemia group (NILG) in Haematologica

2018
AO Cuneo
AOU Alessandria

Spinelli O; Salmoiraghi S; Zanghi P; Cavagna R; Michelato A; Buklijas K; Zannino L; Intermesoli T; Lussana F; Delaini F; Oldani E; Caprioli C; Stefanoni P; Gianfaldoni G; Marmont F; Ferrero D; Terruzzi E; De Paoli L; Rossi G; Borlenghi E; Cavattoni I; Tajana M; Scattolin AM; Mattei D; Corradini P; Campiotti L; Ciceri F; Bernardi M; Todisco E; et alii...

Sequential high-dose cytarabine plus idarubicin improves remission rate and survival duration in adult acute myelogenous leukemia (AML): Randomized trial of the Northern Italy leukemia group (NILG) in Haematologica

2016
AOU Alessandria
AO Ordine Mauriziano
AO Cuneo

Bassan R; Intermesoli T; Masciulli A; Boschini C; Gianfaldoni G; Marmont F; Cavattoni I; Mattei D; Terruzzi E; De Paoli L; Rossi G; Borlenghi E; Ciceri F; Bernardi M; Scattolin AM; Todisco E; Campiotti L; Corradini P; Cortelezzi A; Tajana M; Ferrero D; Cignetti A; Marfisi RM; Delaini F; Zanghì P; Oldani E; Spinelli O; Audisio E; Cortelazzo S; et alii...